Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00614_nanopub.RAFnY70K5FpSG_b4qtiUf0IGl9-ut04bdfWSlpC2mo2B8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00614 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00614 label "DDI between Zolmitriptan and Furazolidone - The MAO inhibitor, furazolidine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing furazolidine are contraindicated. [drugbank_resource:DB00315_DB00614]" assertion.
- drugbank_resource:DB00315_DB00614 identifier "drugbank_resource:DB00315_DB00614" assertion.
- drugbank_resource:DB00315_DB00614 title "DDI between Zolmitriptan and Furazolidone - The MAO inhibitor, furazolidine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing furazolidine are contraindicated." assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00614 assertion.
- drugbank:DB00614 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00614 assertion.